2023
DOI: 10.1038/s41598-023-36996-3
|View full text |Cite
|
Sign up to set email alerts
|

Regulation of microRNA expression by the adaptor protein GRB2

Abstract: Protein interactions with the microRNA (miRNA)-mediated gene silencing protein Argonaute 2 (AGO2) control miRNA expression. miRNA biogenesis starts with the production of precursor transcripts and culminates with the loading of mature miRNA onto AGO2 by DICER1. Here we reveal an additional component to the regulatory mechanism for miRNA biogenesis involving the adaptor protein, growth factor receptor-bound protein 2 (GRB2). The N-terminal SH3 domain of GRB2 is recruited to the PAZ domain of AGO2 forming a tern… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 81 publications
0
1
0
Order By: Relevance
“…Under physiological conditions, various functional inactivate mutants in different domains of GRB2 have been identified, including W36K [16], P49L [17], R86K [17], R86A [18], E89K [19], S90N [20], W139K [16], G162R [21], W193K [16], G203R [22], and P209L [17]. These inactivated mutations in GRB2 result in disabled binding between GRB2 and upstream or downstream proteins, leading to the inhibition of signaling pathways ( sine-containing proteins through its SH2 domain, including the activated epidermal growth factor receptor (EGFR).…”
Section: Introductionmentioning
confidence: 99%
“…Under physiological conditions, various functional inactivate mutants in different domains of GRB2 have been identified, including W36K [16], P49L [17], R86K [17], R86A [18], E89K [19], S90N [20], W139K [16], G162R [21], W193K [16], G203R [22], and P209L [17]. These inactivated mutations in GRB2 result in disabled binding between GRB2 and upstream or downstream proteins, leading to the inhibition of signaling pathways ( sine-containing proteins through its SH2 domain, including the activated epidermal growth factor receptor (EGFR).…”
Section: Introductionmentioning
confidence: 99%